Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis

Effect of rapid colonic transit on stool microbiome and short-chain fatty acids in diarrhoea-predominant irritable bowel syndrome

(2023) Joelle BouSaba et al.   GUT

Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes

(2023) Jonathan P. Jacobs et al.   Microbiome

Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

(2023) Mancai Wang et al.   Frontiers in Immunology

Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review

(2023) Sofia D. Shaikh et al.   Journal of Clinical Medicine

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome

(2022) Taojun Wang et al.   DIGESTIVE DISEASES AND SCIENCES

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease

(2022) Jing Cong et al.   Nutrients

Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation

(2022) Yukari Tanaka et al.   JOURNAL OF GASTROENTEROLOGY

The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome

(2022) Wenxi Jiang et al.   Journal of Neurogastroenterology and Motility

Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome

(2022) Eamonn M. M. Quigley et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome

(2022) Qi Su et al.   Gut Microbes

Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis

(2021) Mei Luo et al.   BMC GASTROENTEROLOGY

Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome

(2021) Ilnar F. Shaidullov et al.   BMC GASTROENTEROLOGY

Methane and fatty acid metabolism pathways are predictive of Low-FODMAP diet efficacy for patients with irritable bowel syndrome

(2021) Ameen Eetemadi et al.   CLINICAL NUTRITION

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

(2021) Dipesh H Vasant et al.   GUT

Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients

(2021) Qing Hua Sun et al.   Journal of Digestive Diseases

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome

(2021) Bani Ahluwalia et al.   Cells

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet

(2021) Kevin Vervier et al.   GUT

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

(2020) Ygor Parladore Silva et al.   Frontiers in Endocrinology

Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

(2020) Ami D. Sperber et al.   GASTROENTEROLOGY

SCFA: mechanisms and functional importance in the gut

(2020) Camille Martin-Gallausiaux et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis

(2020) Caterina Carco et al.   Frontiers in Cellular and Infection Microbiology

Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing

(2019) Ruqiao Duan et al.   Clinical and Translational Gastroenterology

The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes

(2019) Maik Luu et al.   Nature Communications

Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome

(2019) Qinghua Sun et al.   MEDICINE

Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies

(2019) Lin Wang et al.   Journal of the Academy of Nutrition and Dietetics

Corrigendum: The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

(2019) Pei Pei Chong et al.   Frontiers in Microbiology

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome

(2019) Wen-Xue Zhang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome

(2018) Giorgio Gargari et al.   ENVIRONMENTAL MICROBIOLOGY

The Role of Succinate in the Regulation of Intestinal Inflammation

(2018) Jessica Connors et al.   Nutrients

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

(2017) Julien Tap et al.   GASTROENTEROLOGY

Enterotypes in the landscape of gut microbial community composition

(2017) Paul I. Costea et al.   Nature Microbiology

Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?

(2016) Per G. Farup et al.   BMC GASTROENTEROLOGY

The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects

(2015) I. Rangel et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome

(2015) B. P. Chumpitazi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome

(2015) Tamar Ringel-Kulka et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells

(2015) Christopher S. Reigstad et al.   FASEB JOURNAL

Rethinking “Enterotypes”

(2014) Dan Knights et al.   Cell Host & Microbe

The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon

(2014) Norm R. Hurst et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Butyrate-induced colonic hypersensitivity is mediated by mitogen-activated protein kinase activation in rat dorsal root ganglia

(2012) Dabo Xu et al.   GUT

Enterotypes of the human gut microbiome

(2011) Manimozhiyan Arumugam et al.   NATURE

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

(2009) c. tana et al.   NEUROGASTROENTEROLOGY AND MOTILITY